Article information
Full text is only aviable in PDF
Bibliografía
[1.]
T.R. Collins, S.A. Sahn.
Thoracentesis: complications, patient experience and diagnostic value.
Chest, 91 (1987), pp. 817-822
[2.]
B. Naylor.
The pathognomonic cytologic picture of rheumatoid pleuritis.
J Rheumatol, 17 (1990), pp. 673-675
[3.]
H. Motherby, N. Pomjanski, M. Kube, A. Boros, T. Heiden, B. Tribukait, et al.
Diagnostic DNA-flow- vs. -image-cytometry in effusion cytology.
Anal Cell Pathol, 24 (2002), pp. 5-15
[4.]
P.A. Fetsch, A. Simsir, K. Brosky, A. Abati.
Comparison of three commonly used cytologic preparations in effusion immunocytochemestry.
Diagn Cytopathol, 26 (2002), pp. 61-66
[5.]
L.M. Chen, O. Lazcano, J.A. Katzmann, T.K. Kimlinger, C.Y. Li.
The role of conventional cytology, immunocytochemistry and flow cytometric DNS ploidy in the evaluation of body cavity fluids.
Am J Clin Pathol, 109 (1998), pp. 712-721
[6.]
J.E. Heffner, S.A. Sahn, L.K. Brown.
Multilevel likelihood ratios for identifying exudative pleural effusions.
Chest, 121 (2002), pp. 1916-1920
[7.]
V. Villena, A. López Encuentra, J. Echave-Sustaeta, P. Martín Escribano, B. Ortuño de Solo, J. Estenoz Alfaro.
Interferon gamma in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis.
Eur Respir J, 9 (1996), pp. 2635-2639
[8.]
R.W. Light.
Pleural effusions.
N Engl J Med, 346 (2002), pp. 1971-1977
[9.]
S. Romero Candeira, C. Fernández, C. Martín, J. Sánchez Paya, L. Hernández.
Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with herat failure.
Am J Med, 110 (2001), pp. 681-686
[10.]
S. Romero-Candeira, L. Hernández, S. Romero-Brufao, D. Orts, C. Fernández, C. Martín.
Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions?.
Chest, 122 (2002), pp. 1524-1529
[11.]
S. Romero, C. Martín, L. Hernández, J. Verdú, C. Trigo, M. Pérez-Mateo, et al.
Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics.
Chest, 114 (1998), pp. 154-159
[12.]
S. Romero, C. Fernández, J.M. Arrierio, A. Espasa, A. Candela, C. Martín, et al.
CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
Eur Respir J, 9 (1996), pp. 17-23
[13.]
V. Villena, A. López Encuentra, J. Echave-Sustaeta, P. Martín Escribano, B. Ortuño de Solo, J. Estenoz Alfaro.
Diagnostic value of CA 72.4, carcinoembrionic antigen, CA 15.3 and CA 19.9 assay in pleural fluid: A study of 207 patients.
Cancer, 78 (1996), pp. 736-740
[14.]
E. Pérez-Rodríguez, I.J. Pérez-Walton, J.J. Sánchez Hernández, E. Pallarés, J. Rubí, D. Jiménez Castro, et al.
ADA1/ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid.
Respir Med, 93 (1999), pp. 816-821
[15.]
V. Villena, J.A. Navarro Golzálvez, C. García Benayas, J.A. Manzanos, J. Echave, A. López Encuentra, et al.
Rapid automated determination of adenosine deaminase and lysozyme for differentiating tuberculous and nontuberculous pleural effusions.
Clin Chem, 42 (1996), pp. 218-221
[16.]
V. Villena, V. Pérez, F. Pozo, A. López Encuentra, J. Echave-Sustaeta, J. Arenas, et al.
Amylase levels in pleural effusions. A consecutive unselected series of 841 patients.
Chest, 121 (2002), pp. 470-474
[17.]
P. Branca, R.M. Rodriguez, J.T. Royers, D.S. Ayo, J.P. Moyers, R.W. Light.
Routine measurement of pleural fluid amylase is not indicated.
Arch Intern Med, 161 (2001), pp. 228-232
[18.]
F. Rodríguez Panadero, F. López Mejías.
Low glucose and pH levels in malignant pleural effusions.
Am Rev Respir Dis, 139 (1989), pp. 663-667
[19.]
S.A. Sahn, J.r. Good JT.
Pleural fluid pH in malignant effusions.
Ann Intern Med, 108 (1988), pp. 345-349
[20.]
E. Martínez-Moragón, J. Aparicio, J. Sanchís, R. Menéndez, M.C. Rogado, F. Sanchís.
Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases.
Respiration, 65 (1998), pp. 108-113
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
